1. Nursing Capstone
Nursing CapstoneNursing CapstonePermalink: https:// /nursing-capstone/Nursing
CapstoneOrder Description“Barriers to Palliative Care Related to Physicians/ Nurse
Practitioners not ordering it”1. Abstract. Provide a concise (120 word or less) abstract
summarizing the paper. Content should include purpose, methods, results (review/analysis
of literature and implications for practice), and conclusions.2. Introduction. The body of the
paper begins with presentation of the specific phenomenon/topic under investigation. This
section should aIDress why exploration of this topic is important and the potential
implications of such exploration. What is the problem? What question are you posing? A
purpose statement and rationale should be delineated.3. Methods. Identify approach to
literature review (keywords, databases). How many and what categories of papers did you
locate? What is strength of evidence (level, consistency, currency)?4. Review of literature.
Provide an integrative review of pertinent empirical and theoretical literature. What are the
key points to be made? How would you summarize the findings? What conclusions can be
drawn? Assess gaps or limitations in current knowledge.5. Implications for Practice.
Formulate specific nursing implications as a result of completion of this exploration. Discuss
implications within the context of the literature and the nursing area of study. How might
this exploration influence clinical reasoning or patient/nurse management skills? What is
the relevance to primary care? What is the relevance to nursing management? To your
future practice?6. Conclusions. Evaluate achievement of the purpose of the paper. Did the
literature review answer your question and aIDress the problem? Discuss the contribution
of this paper to the advancement of nursing knowledge or practice.7. References. (This
section does not count towards the paper page length). At least 20 references are required.
Only the following peer-reviewed references are allowed: 1) primary research reports; 2)
evidence-based practice guidelines and algorithms; 3) systematic reviews and meta-
analyses; and 4) professional websites with supportive references. One or two general
review articles to introduce the problem from peer-reviewed journals are acceptable. Your
literature is to be synthesized and integrated through-out the paper. The literature review
is NOT to be a series of paragraphs, each summarizing one publication. The literature is to
be used to support the points you are making. The following are NOT acceptable references:
Wikipedia, websites without identified authors, websites with “.com,” textbooks or
encyclopedias (online or offline), patient education brochures or website that were meant
for consumer information. Government sites are acceptable only if material is targeting
professionals, are authored, and include references. Reports MUST be from last 5 yr. If
2. critical for your paper, you may go back 10 yr & note significance of this work. No more than
two sources can be more than 5 yr old.Project Plan Guideline: This is a 2 page summary of
the paper. See example below this.Introduction-what are you proposing to investigate?-
identify problem-pose question– outline purpose-why is this topic important/what is
rationale? (e.g., need for change in practice, emerging health concern, major issue with
morbidity or mortality)-how project could potentially contribute to nursing knowledge and
practice (brief)Review/Analysis of Literature-what approach did you take to review
literature?-how many papers did you locate? What categories (EBP guideline, primary
research, etc.)?-what is their quality? How strong is the evidence? Are the reports current
and valid?-what are gap/limitations in knowledge?-what are the main points to be made?-
how would you summarize the literature? What conclusions does it allow you to
draw?Implications for Practice-what are the implications?-what relevance do the stated
problem and the EBP review have to primary care?-how will this information influence your
future practice?Conclusions -did literature answer your question? AIDress the problem?-
how will it advance nursing knowledge or practice?Project Plan for Capstone (EXAMPLE) (2
pages after the whole paper is completed)IntroductionProblem: Subclinical hypothyroidism
is mild thyroid failure and usually progresses to overt hypothyroidism. It is a fairly common
clinical problem with a prevalence rate of 4.3 to 9.5% in the U.S. population of according the
NHANES III and Colorado study. Subclinical hyperthyroidism can be mild (TSH of 4.5-9
mIU/L) or severe (TSH> 10mIU/L). Screening and management for the disease is
controversial as clinical recommendations differ between professional organizations and
expert opinions.Question: What reference points should be used to treat subclinical
hypothyroidism and what management strategies should be used to prevent cardiovascular
and neuropsychiatric sequellae?Purpose: (Rationale): Several cardiovascular risk factors
have been identified in some patients with subclinical hypothyroidism and include
hypercholesterolemia, atherosclerosis, hyperlipidemia, and cognitive symptoms such as
depression and memory loss. Subclinical hypothyroidism often progresses to overt
hypothyroidism. The progression from subclinical to overt hypothyroidism is subtle and
untreated hypothyroidism can lead to irreversible cardiovascular and neuropsychiatric
symptoms.Review/Analysis of LiteratureAfter defining subclinical hypothyroidism an area
of interest, pertinent articles were identified by searching CINAHL, OVID NURSING,
MEDLINE, National Guideline Clearing House, the Cochrane Database, and the National
Health Services Database (UK). Key search terms were hypothyroidism, thyroid deficiency,
thyroid insufficiency, underactive thyroid, subclinical hypothyroidism, euthyroid, thyroid
peroxidase antibodies, Hashimoto’s thyroiditis. Other key words used were screening,
diagnostics, therapy, treatment, management, consequences, sequelae, hyperlipidemia,
hypercholesteremia, cardiovascular, and cognitive. Research articles produced from 2009
to January 2014 were reviewed. Two older research studies from 2007 and 2008 were also
reviewed. Twenty-six articles were identified as pertinent to the project and assessed for
strength of evidence. Eight of the articles are Level I, four are level II nine are level IV, and
five are level V.Main Points: Subclinical hypothyroidism (SCH) is defined as serum thyroid
stimulation hormone (TSH) concentration > 4.05 mIU/L with free T4 between 0.89-1.79
ng/dL. The prevalence of SCH is more common in women and increases with age. SCH has
3. been shown to be associated with several health problems such asPROJECT PLAN FOR
CAPSTONE 2hyperlipidemia, cardiac dysfunction, cognitive function and progression to
overt hypothyroidism. The most common cause for SCH is autoimmune thyroiditis or
Hashimoto’s disease. Eighty percent of those diagnosed with SCH have anti-thyroid
peroxidase antibodies (TPOAb). TPOAb laboratory testing along with TSH, T3, T4 was found
in the literature to be a recommendation in the evaluation and monitoring of the SCH
patient.Several studies have shown conflicting results in evaluating and treating SCH and
currently there is no consensus on how to manage the disease. Clinical guidelines of
professional societies indicate that the disease must be managed on an individual case basis
including empirically treating symptomatic patients. Many descriptive studies point out that
the sequelae of prolonged untreated SCH may impact an individual’s quality of life. More
research is needed to determine if treating SCH prevents hyperlipidemia and other
cardiovascular problems and whether early treatment prevents progression to overt
hypothyroidismImplications for PracticePrimary care clinicians equipped with an
understanding of the clinical course of SCH and management options based on evidence-
based practice will be able to monitor and manage the SCH patient to achieve optimal
treatment outcomes.Conclusion: The literature has answers the question as to which
reference points should be used to treat subclinical hypothyroidism, however management
strategies to prevent cardiovascular and neuropsychiatric sequelae need further
investigation. Answers to these questions inform the advanced practice nurse on evaluation
and management of this common disease to prevent progression to overt hypothyroidism
and irreversible problems.REFERENCESAghili, F., Khamseh, M.E. Malek, J., Hadian, A.,
Baradaran, H.R., Najafi, L., Emami, Z. (2012). Changes in subtests of Wechsler memory scale
and cognitive function in subjects with subclinical hypothyroidism following treatment with
levothyroxine. Archives of Medical Science 2012, 8(6):2007 1096-1101. doi:
10.5114/aom2012.32423Baris, G., Collet, T., Virgini, V., Bauer, D.C., Gussekloo, J., Cappola,
A.R., Nanchen, D., den Elzen, W.P.J., Balmer, P., Luben, R.N., Iocoviello, M., Triggiani, V. ,
Cornuz, J., Newman, A.B., Khaw, K., Judema, J.W., Westendorp, F.G.J., Vittinghoff, E., Aujesky,
D., Rodondi, N. (2012). Subclinical thyroid dysfunction and the risk of heart failure events:
an individual participant data analysis from six prospective cohorts. Circulation, 126 (9):
.doi:10.1161/CIRCULATIONAHA.112.096024.Biondi, B. (2012). Natural history, diagnosis
and management of subclinical thyroid dysfunction. Best Practice & Research Clinical
Endocrinology & Metabolism, 26 (2012), 431-446. Downloaded from
www.elsevier.com/locate/beemBrenta, G., Vaisman, M., Sgarbi, J.A., Bergoglio, L.M.,
Carvalho de Andrada, C., Bravo, P.P., Orlandi, A.M. & Graf, H. (2013). Clinical Practice
Guidelines for the Management of Hypothyroidism: Task Force on Hypothyroidism of the
Latin American Thyroid Society (LATS). Arquivos Brasilieros de Endocrinologia and
Metabologia 2013;57 (4):265-298.Chakera, A.J., Pearce, S.H.S. & Vaidya, B. (2012).
Treatment for primary hypothyroidism: current approaches and future possibilities. Drug
Design, Development and Therapy, (6), p. 1-11.Cooper, D. S. & Biondi, B. (2012). Subclinical
thyroid disease. The Lancet, 379, 1142-1154. Downloaded from:
www.thelancet.com.Ertugrul, O., Ahmet, U., Asim, E., Gulcin, H.E., Vurak A., Murat, A., Sezai,
U.S., Biter, H.I., Hakan, D.M. (2011). Prevalence of subclinical hypothyroidism among
4. patients with acute myocardial infarction. International Scholary Research Network: ISRN
Endocrinology, 2011. doi: 10:5402/2011/810251Fernandes, R.M.S., Alvarenga, N.B., da
Silva, T.I., & da Rocha, F.F. (2011). Cognitive dysfunction in patients with subclinical
hypothyroidism. Arquivos Brasilieros de Endocrinologia and Metabologia 2011, 55(3):
.doi.org/10.1590/S0004-27302011000300008Garber, J.R., Cobin, R.H., Gharib, H.,
Hennessey, J.V., Klein, I., Mechanick, J.I., Pessah-Pollack, R., Singer, P.A., Woeber, K.A. (2012).
Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American
Association of Clinical Endocrinologists and The American Thyroid Association,18 (6), 989-
1028.Gencer, B., Collet, T., Virgini, V., Bauer, D.C., Gussekloo, J., Cappola, A.R., Nanchen, D.,
den Elzen, W.P.J., Balmer, P., Luben, R.N., Iocoviello, M., Triggiani, V. , Cornuz, J., Newman,
A.B., Khaw, K., Judema, J.W., Westendorp, F.G.J., Vittinghoff, E., Aujesky, D., Rodondi, N.
(2012). Subclinical thyroid dysfunction and the risk of heart failure events: an individual
participant data analysis from six prospective cohorts. Circulation, 126 (9):
.doi:10.1161/CIRCULATIONAHA.112.096024.Ichiki, T. (2010). Thyroid hormone and
atherosclerosis. Vascular Pharmacology, 52 (2010): 151-156. doi:
10.1016/j.vph.2009.09.004Martins, R.M., Fonseca, R.H.A., Duarte, M.M.T., Reuters, V. S.,
Ferreira, M.M., Almeida, C., Buescu, A. , Dos Santos Teiseira, P.F., Vaisman, M. (2011). Impact
of subclinical hypothyroidism treatment in systolic and diastolic cardiac function. Arquivos
Brasilieros de Endocrinologia and Metabologia, 55 (7): 460-467.Nagasaki, T., Yamada, I.M.,
Shirakawa, K., Nagata, Y., Kumeda, Y., Hiura, Y., Tahara, H., Ishimura, E., Nishizawa, Y.
(2009). Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid
patients during normalization of thyroid function: a double-blind, placebo-controlled study.
European Journal of Endocrinology/European Federation of Endocrine Societies, 160(3):
409-15. Doi: 10.1530/EJE-08-074d2Pearce, S.H.S., Brabant, G., Duntas, L.H., Monzani, F.,
Peeters, R.B., Razvi, S. & Wemeau J.L. (2013). 2013 ETA Guideline: Management of
Subclinical Hypothyroidism. European Thyroid Journal, 2, 215-228. DOI:
10:1159/000356507Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C. & Weaver, J.U.
(2007). The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial
function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. The
Journal of Endocrinology and Metabolism, 92(5): 1715-1723. doi: 10.1210/jc.2006 -
1869Rizos, C.V., Elisaf, M.S. & Liberopoulos, E.N. (2011). Effects of thyroid dysfunction on
lipid profile. The Open Cardiovascular Medicine Journal, 2011, 5, 76084Santi, A., Duarte,
M.M.F.F., de Menezes, C.C. & Loro, V.L. (2012). Association of Lipids with Oxidative Stress
Biomarkers in Subclinical Hypothyroidism. International Journal of Endocrinology, 2012, 1-
7. DOI: 10.1155/2012/856359Selmer, C., Olesen, J.B., Hansen, M.L., Lindhardsen, J., Olsen,
A.S., Madsen, J.C., Faber, J., Hansen, P.R., Pedersen, O.D., Torp-Pedersen, C. & Gislason, G.H.
(2012). The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large
population cohort study. BMJ 2012, 345 (e7895). Doi:10.1136/bmj.e7895Sgarbi, J.A.,
Teixeira, P.F.S., Maciel, L.M.Z., Mazeto, G.M.F.S., Vaisman, M., Montenegro, J., Ward, L.S.
(2013). The Brazilian consensus for the clinical approach and treatment of subclinical
hypothyroidism in adults: recommendations of the thyroid Department of the Brazilian
Society of Endocrinology and Metabolism. Arquivos Brasilieros de Endocrinologia and
Metabologia 2013;57 (3):166-183.Shakoor, S.K.A., Aldibbiat, A., Ingoe, L.E., Campbell, S.C.,
5. Sibal, L., Shaw, J., Home, P.D., Razvi, S. & Weaver, J.U. (2009). Endothelial progenitor cells in
subclinical hypothyroidism: the effect of thyroid hormone replacement. Journal of
Endocrinology and Metabolism, 95(1): 319-322. doi: 10.1210/jc.2009-1421Singh, S.,
Duggal, J., Molnar J., Maldonado, F., Barsano, C. & Arora, R. (2008). Impact of subclinical
thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: A
meta-analysis. International Journal of Cardiology, 125: 41-48.Tian, L. , Gao, C. Liu, J. &
Zhang, X. (2010). Increased carotid arterial stiffness in subclinical hypothyroidism. Journal
of Internal Medicine, 21, 560-563. doi:10.1016/j/ejim.2010.08.005Tseng, F., Wen-Yuan, L.
Cheng-Chieh, L., Long-Teng, L. Tsai-Chung, L. Pei-Kun, S. & Kuo-Chin, H. (2012). Subclinical
hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality
in adults. Journal of the American College of Cardiology, 60 (8), 730-737. Downloaded from:
https://dx.doi.org/10.1016/j.jacc.2012.03.047Velkoska, N.K., Bosevski, M., Dimitrovski, C. &
Krstevska, B. (2011). Subclinical hypothyroidism and risk to carotid atherosclerosis. .
Arquivos Brasilieros de Endocrinologia and Metabologia, 55 (7):475-480.Villar H.C.C.E.,
Saconato H., Valente, O. & Atallah, A.N. (2009). Thyroid Hormone Replacement for
Subclinical Hypothyroidism (Review). The Cochrane Collaboration, The Cochrane Library
(1), 1-59. Downloaded from: https://www.thecochranelibrary.comYurtdas, M., Gen, R.,
Ozcan, T & Aydin, M.K. (2012). Assessment of the elasticity properties of the ascending
aorta in patients with subclinical hypothyroidism by tissue Doppler imaging. Arquivos
Brasilieros de Endocrinologia and Metabologia 2013;57 (2): 132-138.
